Filters: First Letter Of Last Name is F [Clear All Filters]
Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. European journal of immunology. 2002;32:457-66.
Measurement of cyclic variation in ultrasonic integrated backscatter in conscious, unsedated, clinically normal dogs. Am J Vet Res. 1997;58(10):1055-9.
Managing hypoglycaemia. Practitioner. 2005;249(1673):564, 566, 568 passim.
[Does recurrent exposure to severe hypoglycaemia affect cognitive function?]. Pol Arch Med Wewn. 2007;117(8):341-2.
Morbidity of hypoglycemia in type 1 diabetes. Diabetes Res Clin Pract. 2004;65 Suppl 1:S47-52.
Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34 Suppl 2:S132-7.
How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev. 2008;24(2):87-92.
Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling. Endocrinology. 2006;147:773-81.
Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation. The Journal of endocrinology. 2004;183:365-74.
Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet. 2010;42(5):430-5.
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature. 2010;464(7289):728-32.
Characterization of an abdominal aortic velocity waveform in patients with abdominal aortic aneurysm. Ultrasound Med Biol. 2008;34(1):73-80.
Acoustic speed and attenuation coefficient in sheep aorta measured at 5-9 MHz. Ultrasound Med Biol. 2006;32(6):971-80.
Fluid-structure interaction in axially symmetric models of abdominal aortic aneurysms. Proc Inst Mech Eng H. 2009;223(2):195-209.
Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension. 2004;44:681-8.
The TCF7L2 diabetes risk variant is associated with HbA₁(C) levels: a genome-wide association meta-analysis. Ann Hum Genet. 2010;74(6):471-8.
Enoxaparin treatment in unstable coronary artery disease: international cost savings. Chest. 2002;121:666-7.
COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart. 2009;95(9):689-92.
Risk stratification in acute coronary syndromes. Rev Esp Cardiol. 2010;63(6):629-32.
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Annals of internal medicine. 2007;147:304-10.
Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). European heart journal. 2002;23:1177-89.
Dual or single antiplatelet therapy with anticoagulation? Lancet. 2013;381(9872):1080-1.
Nice guidance on the investigation of chest pain. Heart. 2010;96(12):903-6.